Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CE - US1508701034 - Common Stock

41.65 USD
+1.17 (+2.89%)
Last: 11/28/2025, 8:17:33 PM
41.65 USD
0 (0%)
After Hours: 11/28/2025, 8:17:33 PM
Fundamental Rating

3

Taking everything into account, CE scores 3 out of 10 in our fundamental rating. CE was compared to 81 industry peers in the Chemicals industry. CE has a bad profitability rating. Also its financial health evaluation is rather negative. CE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CE was profitable.
CE had a positive operating cash flow in the past year.
Of the past 5 years CE 4 years were profitable.
CE had a positive operating cash flow in each of the past 5 years.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

CE's Return On Assets of -13.95% is on the low side compared to the rest of the industry. CE is outperformed by 80.25% of its industry peers.
Looking at the Return On Equity, with a value of -78.22%, CE is doing worse than 85.19% of the companies in the same industry.
With a Return On Invested Capital value of 3.60%, CE perfoms like the industry average, outperforming 49.38% of the companies in the same industry.
CE had an Average Return On Invested Capital over the past 3 years of 4.41%. This is in line with the industry average of 6.07%.
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROIC 3.6%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

With a Operating Margin value of 8.72%, CE perfoms like the industry average, outperforming 50.62% of the companies in the same industry.
CE's Operating Margin has declined in the last couple of years.
CE has a Gross Margin of 21.33%. This is in the lower half of the industry: CE underperforms 62.96% of its industry peers.
CE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CE is destroying value.
Compared to 1 year ago, CE has more shares outstanding
The number of shares outstanding for CE has been reduced compared to 5 years ago.
Compared to 1 year ago, CE has a worse debt to assets ratio.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that CE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CE (1.46) is worse than 66.67% of its industry peers.
CE has a debt to FCF ratio of 12.55. This is a negative value and a sign of low solvency as CE would need 12.55 years to pay back of all of its debts.
CE has a Debt to FCF ratio (12.55) which is in line with its industry peers.
CE has a Debt/Equity ratio of 2.99. This is a high value indicating a heavy dependency on external financing.
CE has a Debt to Equity ratio of 2.99. This is amonst the worse of the industry: CE underperforms 85.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Altman-Z 1.46
ROIC/WACC0.5
WACC7.16%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.63 indicates that CE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.63, CE is doing worse than 66.67% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that CE should not have too much problems paying its short term obligations.
CE has a Quick ratio of 1.04. This is in the lower half of the industry: CE underperforms 65.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.04
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for CE have decreased strongly by -47.48% in the last year.
CE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.59% yearly.
Looking at the last year, CE shows a decrease in Revenue. The Revenue has decreased by -7.34% in the last year.
CE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.30% yearly.
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%

3.2 Future

Based on estimates for the next years, CE will show a small growth in Earnings Per Share. The EPS will grow by 3.78% on average per year.
CE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.25% yearly.
EPS Next Y-47.45%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
EPS Next 5Y3.78%
Revenue Next Year-5.37%
Revenue Next 2Y-1.66%
Revenue Next 3Y0.05%
Revenue Next 5Y-0.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.68, the valuation of CE can be described as reasonable.
88.89% of the companies in the same industry are more expensive than CE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.31, CE is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.03, the valuation of CE can be described as very cheap.
CE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CE is cheaper than 91.36% of the companies in the same industry.
CE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
Industry RankSector Rank
PE 8.68
Fwd PE 7.03
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

CE's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CE indicates a rather cheap valuation: CE is cheaper than 95.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.45
EV/EBITDA 9.75
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as CE's earnings are expected to decrease with -2.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%

3

5. Dividend

5.1 Amount

CE has a yearly dividend return of 0.30%, which is pretty low.
CE's Dividend Yield is slightly below the industry average, which is at 3.94.
Compared to an average S&P500 Dividend Yield of 2.34, CE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of CE has a limited annual growth rate of 3.06%.
CE has been paying a dividend for at least 10 years, so it has a reliable track record.
CE has decreased its dividend recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of CE are negative and hence is the payout ratio. CE will probably not be able to sustain this dividend level.
CE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-2.78%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (11/28/2025, 8:17:33 PM)

After market: 41.65 0 (0%)

41.65

+1.17 (+2.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners107.4%
Inst Owner Change-3.23%
Ins Owners0.27%
Ins Owner Change0.94%
Market Cap4.56B
Revenue(TTM)9.71B
Net Income(TTM)-3.09B
Analysts72
Price Target55.87 (34.14%)
Short Float %7.08%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-2.78%
Div Incr Years0
Div Non Decr Years1
Ex-Date10-28 2025-10-28 (0.03)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.25%
Min EPS beat(2)-0.14%
Max EPS beat(2)6.64%
EPS beat(4)3
Avg EPS beat(4)17.03%
Min EPS beat(4)-0.14%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)2.25%
EPS beat(16)8
Avg EPS beat(16)2.68%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-4.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.63%
PT rev (1m)0.38%
PT rev (3m)-0.08%
EPS NQ rev (1m)-5.9%
EPS NQ rev (3m)-17.13%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-2.69%
Revenue NQ rev (1m)-3.45%
Revenue NQ rev (3m)-4.04%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 8.68
Fwd PE 7.03
P/S 0.47
P/FCF 4.45
P/OCF 3.29
P/B 1.15
P/tB N/A
EV/EBITDA 9.75
EPS(TTM)4.8
EY11.52%
EPS(NY)5.92
Fwd EY14.22%
FCF(TTM)9.35
FCFY22.45%
OCF(TTM)12.68
OCFY30.43%
SpS88.68
BVpS36.11
TBVpS-31.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number62.45
Profitability
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROCE 4.59%
ROIC 3.6%
ROICexc 3.9%
ROICexgc 6.84%
OM 8.72%
PM (TTM) N/A
GM 21.33%
FCFM 10.55%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexgc growth 3Y-25.53%
ROICexgc growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Debt/EBITDA 7.29
Cap/Depr 47.03%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 85.63%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.04
Altman-Z 1.46
F-Score4
WACC7.16%
ROIC/WACC0.5
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
EPS Next Y-47.45%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
EPS Next 5Y3.78%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%
Revenue Next Year-5.37%
Revenue Next 2Y-1.66%
Revenue Next 3Y0.05%
Revenue Next 5Y-0.25%
EBIT growth 1Y-23%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.28%
EBIT Next 3Y12.65%
EBIT Next 5Y9.04%
FCF growth 1Y-0.29%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-13.79%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CE.


What is the valuation status for CE stock?

ChartMill assigns a valuation rating of 6 / 10 to CELANESE CORP (CE). This can be considered as Fairly Valued.


What is the profitability of CE stock?

CELANESE CORP (CE) has a profitability rating of 3 / 10.


Can you provide the financial health for CE stock?

The financial health rating of CELANESE CORP (CE) is 2 / 10.


What is the expected EPS growth for CELANESE CORP (CE) stock?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to decline by -47.45% in the next year.